731 related articles for article (PubMed ID: 25421826)
41. Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials.
Zhu B; Chen N; Lin Y; Ren H; Zhang W; Wang W; Pan X; Yu H
Nephrol Dial Transplant; 2007 Jul; 22(7):1933-42. PubMed ID: 17405792
[TBL] [Abstract][Full Text] [Related]
42. Immunosuppressive therapies for the induction treatment of proliferative lupus nephritis: a systematic review and network metaanalysis.
Tian SY; Feldman BM; Beyene J; Brown PE; Uleryk EM; Silverman ED
J Rheumatol; 2014 Oct; 41(10):1998-2007. PubMed ID: 25225281
[TBL] [Abstract][Full Text] [Related]
43. [Mycophenolate mofetil for the treatment of lupus nephritis. The case of lupus nephritis--class IV according to WHO--treated with mycophenolate mofetil].
Suszek D; Wielosz E; Majdan M
Ann Acad Med Stetin; 2010; 56 Suppl 1():91-4. PubMed ID: 21365951
[TBL] [Abstract][Full Text] [Related]
44. Combination therapy of mycophenolate mofetil and tacrolimus in lupus nephritis.
Lanata CM; Mahmood T; Fine DM; Petri M
Lupus; 2010 Jul; 19(8):935-40. PubMed ID: 20388722
[TBL] [Abstract][Full Text] [Related]
45. Outcomes in patients with active lupus nephritis requiring immunosuppressives who never received cyclophosphamide.
Urowitz MB; Ibañez D; Ali Y; Gladman DD
J Rheumatol; 2007 Jul; 34(7):1491-6. PubMed ID: 17610320
[TBL] [Abstract][Full Text] [Related]
46. Mycophenylate mofetil: what role in the treatment of lupus?
Dooley MA
Lupus; 2006; 15(3):179-82. PubMed ID: 16634373
[TBL] [Abstract][Full Text] [Related]
47. Towards new avenues in the management of lupus glomerulonephritis.
Mok CC
Nat Rev Rheumatol; 2016 Apr; 12(4):221-34. PubMed ID: 26729459
[TBL] [Abstract][Full Text] [Related]
48. [Lupus-nephritis--diagnosis and treatment].
Norby GE; Lerang K; Holdaas H; Gran JT; Strøm EH; Draganov B; Os I; Hartmann A; Gilboe IM
Tidsskr Nor Laegeforen; 2010 Jun; 130(11):1140-4. PubMed ID: 20531500
[TBL] [Abstract][Full Text] [Related]
49. Con: The use of calcineurin inhibitors in the treatment of lupus nephritis.
Fernandez Nieto M; Jayne DR
Nephrol Dial Transplant; 2016 Oct; 31(10):1567-71. PubMed ID: 27591328
[TBL] [Abstract][Full Text] [Related]
50. Human clinical trials in lupus nephritis.
Dooley MA; Falk RJ
Semin Nephrol; 2007 Jan; 27(1):115-27. PubMed ID: 17336693
[TBL] [Abstract][Full Text] [Related]
51. Current management of lupus nephritis.
Houssiau FA; Lauwerys BR
Best Pract Res Clin Rheumatol; 2013 Jun; 27(3):319-28. PubMed ID: 24238689
[TBL] [Abstract][Full Text] [Related]
52. Celebrating the ACP centennial: from the Annals archive.
Cotton D
Ann Intern Med; 2015 Jan; 162(1):70. PubMed ID: 25560715
[No Abstract] [Full Text] [Related]
53. Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis.
Choi CB; Won S; Bae SC
Lupus; 2018 May; 27(6):1007-1011. PubMed ID: 29448881
[TBL] [Abstract][Full Text] [Related]
54. Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis.
Arends S; Berden JH; Grootscholten C; Derksen RH; Berger SP; de Sévaux RG; Voskuyl AE; Bijl M;
Neth J Med; 2014 Nov; 72(9):481-90. PubMed ID: 25431394
[TBL] [Abstract][Full Text] [Related]
55. Induction therapy for active lupus nephritis: mycophenolate mofetil is superior to cyclophosphamide.
Elliott JR; Manzi S
Nat Clin Pract Rheumatol; 2006 Jul; 2(7):354-5. PubMed ID: 16932717
[No Abstract] [Full Text] [Related]
56. What is the ideal duration of maintenance therapy for lupus nephritis?
Yap DYH; Chan TM
Expert Rev Clin Immunol; 2022 May; 18(5):425-427. PubMed ID: 35306959
[No Abstract] [Full Text] [Related]
57. Dutch guidelines for diagnosis and therapy of proliferative lupus nephritis.
van Tellingen A; Voskuyl AE; Vervloet MG; Bijl M; de Sévaux RG; Berger SP; Derksen RH; Berden JH;
Neth J Med; 2012 May; 70(4):199-207. PubMed ID: 22641632
[TBL] [Abstract][Full Text] [Related]
58. Comparative efficacy and safety of tacrolimus, mycophenolate mofetil, azathioprine, and cyclophosphamide as maintenance therapy for lupus nephritis : A Bayesian network meta-analysis of randomized controlled trials.
Lee YH; Song GG
Z Rheumatol; 2017 Dec; 76(10):904-912. PubMed ID: 27638015
[TBL] [Abstract][Full Text] [Related]
59. Addition of cyclosporine/tacrolimus for pediatric relapsed lupus nephritis during mycophenolate mofetil maintenance therapy.
Mao Y; Yin L; Huang H; Zhou Z; Chen T; Zhou W
J Int Med Res; 2019 Jan; 47(1):105-113. PubMed ID: 30208769
[TBL] [Abstract][Full Text] [Related]
60. Maintenance therapy for lupus nephritis--something old, something new.
Balow JE; Austin HA
N Engl J Med; 2004 Mar; 350(10):1044-6. PubMed ID: 14999117
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
